SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Cell Therapeutics, Inc.' Pixuvri® Approved in European Union as Monotherapy to Treat Adult Patients With Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas